Patient Monitoring Devices are used to observe, measure, and record vital signs in patients. A Spirometer is a device designed to measure the amount of air inhaled or exhaled by a patient and the rate at which the air is moved into or out of the lungs in a lung function test. GlobalData uses proprietary data and analytics to provide a comprehensive report on the spirometers market in Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the spirometers market in Japan was Chest M.I. followed by Vyaire Medical, Vitalograph, Cosmed, Minato Medical Science, Schiller, Recorders & Medicare Systems, Welch Allyn, Uscom and Koninklijke Philips.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Spirometers are used for diagnosis and monitoring diseases such as asthma, chronic obstructive pulmonary disease. Spirometers captures the Portable and Handheld Spirometer devices, as well as the PC Based Spirometer devices. Fixed Tabletop Devices are not included in this. A PC Based Spirometer is a device that consists of a mouthpiece, connectors & tubing, and monitor. Portable and Handheld Spirometers are Handheld or Tabletop Devices that consist of a mouthpiece, nose plug, and indicator.
The spirometers market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size spirometers in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
